Related references
Note: Only part of the references are listed.The different natural estrogens promote endothelial healing through distinct cell targets
Morgane Davezac et al.
JCI INSIGHT (2023)
Regulation of human endothelial cell migration by oral contraceptive estrogen receptor ligands
Aida Dama et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2023)
A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2-vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life
Ulysse Gaspard et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2023)
Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review
Marina Sprem Goldstajn et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2023)
Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia
K. Gemzell-Danielsson et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause
Celine Gerard et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2022)
Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials * , **
Jeffrey T. Jensen et al.
CONTRACEPTION (2022)
Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women
Andrew M. Kaunitz et al.
CONTRACEPTION (2022)
A novel estetrol-containing combined oral contraceptive: European expert panel review
Kristina Gemzell-Danielsson et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2022)
Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview
David F. Archer et al.
JOURNAL OF CLINICAL MEDICINE (2022)
RF34 | PMON202 The Human Metabolic Profile of Estetrol
Céline Gérard et al.
Journal of the Endocrine Society (2022)
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials
Melissa J. Chen et al.
CONTRACEPTION (2022)
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
Laure Morimont et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Estetrol prevents Western diet-induced obesity and atheroma independently of hepatic estrogen receptor α
Melissa Buscato et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)
Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone
Christine Klipping et al.
CONTRACEPTION (2021)
Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer
Marcus Schmidt et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function
Ingrid Duijkers et al.
CONTRACEPTION (2021)
Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results
Mitchell D. Creinin et al.
CONTRACEPTION (2021)
Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk
Laure Morimont et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
The 3,4-Quinones of Estrone and Estradiol Are the Initiators of Cancer whereas Resveratrol and N-acetylcysteine Are the Preventers
Ercole Cavalieri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
Anne Gallez et al.
CANCERS (2021)
Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)
Herjan J. T. Coelingh Bennink et al.
EUROPEAN UROLOGY OPEN SCIENCE (2021)
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant
Julien Jacquemetton et al.
BREAST CANCER RESEARCH (2021)
Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need
Jonathan Douxfils et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Unconventional Estrogen Signaling in Health and Disease
Christina L. Faltas et al.
ENDOCRINOLOGY (2020)
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters
Jonathan Douxfils et al.
CONTRACEPTION (2020)
A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety
Ulysse Gaspard et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2020)
ERα-Mediated Nuclear Sequestration of RSK2 Is Required for ER+ Breast Cancer Tumorigenesis
Katarzyna A. Ludwik et al.
CANCER RESEARCH (2018)
Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis
Marie-Cecile Valera et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Communication between genomic and non-genomic signaling events coordinate steroid hormone actions
Sandi R. Wilkenfeld et al.
STEROIDS (2018)
Nitric Oxide: From Good to Bad
Paul M. Vanhoutte
ANNALS OF VASCULAR DISEASES (2018)
Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control
Dan Apter et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2017)
Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
Jen-Hwey Chiu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study
Herjan J. T. Coelingh Bennink et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)
Contemporary Hormonal Contraception and the Risk of Breast Cancer
Lina S. Morch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Estetrol, a Fetal Selective Estrogen Receptor Modulator, Acts on the Vagina of Mice through Nuclear Estrogen Receptor α Activation
Thibaut Benoit et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Thirty Years of Saying NO Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator
Paul M. Vanhoutte et al.
CIRCULATION RESEARCH (2016)
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA)
Dan Apter et al.
CONTRACEPTION (2016)
The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells
Natalia F. Smirnova et al.
CIRCULATION RESEARCH (2015)
A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24/4 regimen
Ingrid J. M. Duijkers et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2015)
Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms
Celine Gerard et al.
ONCOTARGET (2015)
Oestetrol stimulates proliferation and oestrogen receptor expression in breast cancer cell lines: Comparison of four oestrogens
Shunyu Liu et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2015)
Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation
C. Gerard et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Antiestrogenic effects of the fetal estrogen estetrol in women with estrogen-receptor positive early breast cancer
Christian F. Singer et al.
CARCINOGENESIS (2014)
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation
Anne Abot et al.
EMBO MOLECULAR MEDICINE (2014)
Hormonal contraception, thrombosis and age
Ojvind Lidegaard
EXPERT OPINION ON DRUG SAFETY (2014)
Estrogen biology: New insights into GPER function and clinical opportunities
Eric R. Prossnitz et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Coagulation in liver toxicity and disease: Role of hepatocyte tissue factor
Anna K. Kopec et al.
THROMBOSIS RESEARCH (2014)
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton
Maria Silvia Giretti et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Prevention of Obesity and Insulin Resistance by Estrogens Requires ERa Activation Function-2 ( ERαAF-2), Whereas ERαAF-1 Is Dispensable
Sandra Handgraaf et al.
DIABETES (2013)
The AF-1 Activation Function of Estrogen Receptor α Is Necessary and Sufficient for Uterine Epithelial Cell Proliferation In Vivo
Anne Abot et al.
ENDOCRINOLOGY (2013)
Estrogen Reduces Lipid Content in the Liver Exclusively from Membrane Receptor Signaling
Ali Pedram et al.
SCIENCE SIGNALING (2013)
Hormonal contraception and venous thromboembolism
Ojvind Lidegaard et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2012)
Vasorelaxing effects of estetrol in rat arteries
Rob H. P. Hilgers et al.
JOURNAL OF ENDOCRINOLOGY (2012)
Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk
Sandhya Pruthi et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Non-nuclear Estrogen Receptor Signaling in the Endothelium
Qian Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Roles of transactivating functions 1 and 2 of estrogen receptor-α in bone
A. E. Borjesson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers
Ercole L. Cavalieri et al.
FUTURE ONCOLOGY (2010)
The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy
C. N. Bagot et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Mechanisms of Estrogen-Induced Venous Thromboembolism
Svetlana N. Tchaikovski et al.
THROMBOSIS RESEARCH (2010)
Hormone Action in the Mammary Gland
Cathrin Brisken et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Development of a Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry Method for Analysis of Stable 4-Hydroxyequilenin-DNA Adducts in Human Breast Cancer Cells
Zhican Wang et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Breast Cancer Risk in Postmenopausal Women Using Estradiol-Progestogen Therapy
Heli Lyytinen et al.
OBSTETRICS AND GYNECOLOGY (2009)
Effect of combined oral contraceptives on breast epithelial proliferation in young women
Debora Garcia y Narvaiza et al.
BREAST JOURNAL (2008)
First human exposure to exogenous single-dose oral estetrol in early postmenopausal women
M. Visser et al.
CLIMACTERIC (2008)
Maternal and fetal estetrol levels during pregnancy
F. Coelingh Bennink et al.
CLIMACTERIC (2008)
Estetrol does not bind sex hormone binding globulin or increase its production by human HepG2 cells
G. L. Hammond et al.
CLIMACTERIC (2008)
Preventive effect of oral estetrol in a menopausal hot flush model
C. F. Holinka et al.
CLIMACTERIC (2008)
Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model
H. J. T. Coelingh Bennink et al.
CLIMACTERIC (2008)
Estrogenic uterovaginal effects of oral estetrol in the modified Allen-Doisy test
A. -M. Heegaard et al.
CLIMACTERIC (2008)
In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism
M. Visser et al.
CLIMACTERIC (2008)
Ovulation inhibition by estetrol in an in vivo model
Herian J. T. Coelingh Bennink et al.
CONTRACEPTION (2008)
Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women
Marianne Canonico et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Sex hormone-binding globulin - A surrogate marker for the prothrombic effects of combined oral contraceptives (vol 190, pg 332, 2004)
M van Roolien et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Breast cancer and hormone-replacement therapy in the Million Women Study
E Banks et al.
LANCET (2003)
Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry
J Embrechts et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2003)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Vasculoprotective effects of oestrogens
JF Arnal et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2001)
Effects of oral contraceptives on breast epithelial proliferation
E Isaksson et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Share Paper
